Resume-aware faculty matching

Find professors who actually fit you

Review faculty evidence in public, then use the workspace to turn your background into a shortlist, outreach, and meeting prep.

Profile-awarePaper evidenceSix agents
Ke Cheng

Ke Cheng

North Carolina State University · Molecular Biomedical Sciences

Active 2005–2025

h-index61
Citations11.9k
Papers16781 last 5y
Funding$16.3M2 active

Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.

See your match with Ke Cheng — sign in to PhdFit.Sign in

About

Sarah Ho is the CVM Director of Student Engagement at the College of Veterinary Medicine at NC State University. Her role involves fostering student development and engagement within the college community. The page highlights her contact information and her position as a key figure in student involvement, but does not provide specific details about her research focus, background, or key contributions in the field of veterinary medicine or biomedical sciences.

Research topics

  • Medicine
  • Biology
  • Internal medicine
  • Cancer research
  • Pathology
  • Cell biology
  • Chemistry
  • Bioinformatics
  • Immunology
  • Anatomy

Selected publications

  • Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis

    Nature Communications · 2020 · 432 citations

    Senior authorCorresponding

    Idiopathic pulmonary fibrosis (IPF) is a fatal and incurable form of interstitial lung disease in which persistent injury results in scar tissue formation. As fibrosis thickens, the lung tissue loses the ability to facilitate gas exchange and provide cells with needed oxygen. Currently, IPF has few treatment options and no effective therapies, aside from lung transplant. Here we present a series of studies utilizing lung spheroid cell-secretome (LSC-Sec) and exosomes (LSC-Exo) by inhalation to t…

  • Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs

    Theranostics · 2020 · 394 citations

    Senior authorCorresponding

    : Here we demonstrate that the exosomes' ability to target the parent cancer is a phenomenon that opens up new ways to devise targeted therapies to deliver anti-tumor drugs.

  • An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs

    Science Translational Medicine · 2020 · 204 citations

    Senior authorCorresponding

    Cell therapy has been a promising strategy for cardiac repair after injury or infarction; however, low retention and engraftment of transplanted cells limit potential therapeutic efficacy. Seeding scaffold material with cells to create cardiac patches that are transplanted onto the surface of the heart can overcome these limitations. However, because patches need to be freshly prepared to maintain cell viability, long-term storage is not feasible and limits clinical applicability. Here, we devel…

  • A Zebrafish Model of Metastatic Colonization Pinpoints Cellular Mechanisms of Circulating Tumor Cell Extravasation

    Frontiers in Oncology · 2021 · 19 citations

    ) as consistently upregulated and central to the ECM gene regulatory network (p < 0.05). Versican expression is prognostic for a poorer metastasis-free and overall survival in patients with osteosarcoma. Together, our results provide a novel experimental framework to study discrete steps in the metastatic process. Using this system, we identify the versican/ECM network dysregulation as a potential contributor to osteosarcoma circulating tumor cell metastasis.

  • Plant-derived hydrogel and photosynthetic nano-units for myocardial infarction therapy

    Nature Communications · 2025-08-18 · 11 citations

    articleOpen access

    Ischemic injury and reperfusion injury collectively determine the total infarct size, a major prognostic factor following myocardial infarction (MI). Therefore, addressing both ischemic and reperfusion stages could substantially reduce infarct size and improve clinical outcomes. In this study, we develop a two-component therapeutic system from different parts of Glycyrrhiza: a functional hydrogel made from glycyrrhizic acid extracted from the stem and root, and nanosized chloroplast units (NCUs)…

Recent grants

Frequent coauthors

  • Shiqi Hu

    100 shared
  • Junnan Tang

    Henan Provincial Center for Disease Control and Prevention

    81 shared
  • Zhenhua Li

    Institute of Botany

    79 shared
  • Ke Huang

    North Carolina State University

    74 shared
  • Jhon Cores

    University of North Carolina at Chapel Hill

    62 shared
  • Dashuai Zhu

    55 shared
  • Teng Su

    50 shared
  • Phuong‐Uyen Dinh

    North Carolina State University

    48 shared

Education

  • Ph.D., Animal Science

    University of California, Davis

    2000
  • M.S., Animal Science

    University of California, Davis

    1997
  • B.S., Animal Science

    University of California, Davis

    1995

Similar researchers at North Carolina State University

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Ke Cheng

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup